New French Proteomics Firm Launches | GenomeWeb Daily News ...

The technology was developed by researchers at the Exploring the Dynamics of Proteomes laboratory and was described in a 2007 interview with Brun by GenomeWeb Daily News The University of Pennsylvania's Hakon Hakonarson and his colleagues describe... NEW YORK (GenomeWeb News) – Promise Advanced Proteomics, a French fee-for-service proteomics firm providing mass spectrometry-based absolute quantification services, has launched. The company officially launched late last month, said Virginie Brun, the company's co-founder and chief scientific officer who was part of a team that developed the company's technology. Based in Grenoble, France, Promise is a spinout of the Exploring the Dynamics of Proteomes laboratory at the National Institute of Health and Medical Research, the French Atomic Energy and Alternative Energies Commission, and Université Joseph... ANNOVAR can be run on a desktop computer, the team reports, and takes only four minutes to perform gene-based annotation and 15 to perform variants reduction on 4. Specifically, it employs a technology called Protein Standard Absolute Quantification for developing full-length isotopically-labeled proteins. The proteins can be used for quantitative proteomics and analytical research. DeCode Genetics' Kari Stefansson and his colleagues show an association between common variants near CAV1 and CAV2 and primary open-angle glaucoma. Promise provides services for the development of therapeutic proteins and biomarkers. GenomeQuest said this week that CEO Ron Ranauro has resigned and will be replaced by Richard Resnick as acting CEO. "The risk variant identified here is located close to CAV1 and CAV2, both of which are expressed in the trabecular meshwork and retinal ganglion cells that are involved in the pathogenesis of POAG," the authors write. In their genome-wide association study, the DeCode-led team gentoypes 1,263 affected individuals and 34,877 controls from Iceland. He formerly was CEO of Mosaic Bioinformatics , and he was global bioinformatics software head at Wyeth. 7 million variants, "making it practical to handle hundreds of human genomes in a day....

Read more...

Genomics and proteomics

The Promise of Research: Now and in the Future





Kinexus Bioinformatics Launches Online Proteomics DataBase

/PRNewswire/ - Kinexus Bioinformatics Corporation, a world-leader in molecular intelligence research, announced a major expansion in its KiNET DataBank ( http://www.kinexus.ca/ourServices/kinet/kinet.html ) for the study of cell communication systems with the launch of the KiNET-Antibody Microarray (KiNET-AM) website. This open access, online resource for the scientific community features over 1.5 million measurements of the levels and phosphorylation status of over 400 distinct protein kinases and their targets in over 2000 tissue and cell specimens. All of the data was generated in-house at Kinexus with its proprietary Kinex™ antibody microarrays with biological samples provided over the last 5 years by over 600 academic and industrial laboratories from around the globe. KiNET-AM complements the KiNET-Immunoblotting (KiNET-IB) DataBase that was first launched in 2005. KiNET-IB contains over 200,000 measurements of protein phosphorylation and expression as determined with Kinexus' Kinetworks™ Multi-immunoblotting technology. Together, KiNET-AM and KiNET-IB provide the world's largest repository of semi-quantitative proteomics data with antibody probes.

Which of the following statements regarding proteomics is correct?

A. Proteomics is the study of protein interaction within a cell.
B. Proteomics involves the complete analysis of the prokaryotes.
C. Proteomics is a straightforward task that is technically simple.
D. Proteomics is the


D.

What is the difference between genomics, proteomics and metabolomics?



Genomics is the study of all the genes an organism has.

Proteomics is the study of all the proteins made by the organism and the conditions under which the organism makes them (growth phase, always, shock,...)

Metabolomics



Leave a Reply